Funder: European Commission
Due Dates (Anticipated): December 2026 (full application submission, projected)
Funding Amounts: €18,000,000 total for this topic; typical project budget €5.5–9 million; project duration 24–48 months; funding rate 60% (up to 80% for exceptional utility)
Summary: Supports advanced research and development of innovative medical countermeasures to enhance EU preparedness against chemical, biological, radiological, and nuclear (CBRN) threats.
Key Information: This is a forecasted call—dates and details may change; check the program page for updates.